Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 80INDUSTRY 25NIH 5OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Leukemia 3Preleukemia 2Precancerous Conditions 2Neoplasms by Histologic Type 2Neoplasms 2Lymphoproliferative Disorders 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Lymphatic Diseases 2Leukemia, Myeloid 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphoid 2Leukemia, B-Cell 2Immunoproliferative Disorders 2Immune System Diseases 2Hematologic Diseases 2Bone Marrow Diseases 2Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Sarcoma, Alveolar Soft Part 1Primary Myelofibrosis 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1

Interventions

Etoposide 5Rituximab 4Radiotherapy 4Methotrexate 4Cytarabine 4Cyclophosphamide 3Cisplatin 3Vincristine 2Specimen Handling 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2Gemcitabine 2Fenretinide 2Doxorubicin 2Carmustine 2venetoclax 1tucatinib 1temsirolimus 1plerixafor 1pertuzumab 1palbociclib 1olaparib 1merphos 1liposomal amphotericin B 1ixabepilone 1ibrutinib 1ibritumomab tiuxetan 1fludarabine 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Non-Hodgkin × fludarabine × Clear all
NCT05077527 2026-04-14

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

AIDS Malignancy Consortium

Phase 1 Recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡